Let’s not get any crazy ideas here and increase our...

Let’s not get any crazy ideas here and increase our expectations. Unfortunately (for day traders and short termers) there is no big upfronts or milestones in the next few deals unless something comes from left field. Fortunate for long termers then are a string of smaller deals that have a potential huge back end with hopeful upfront, development and milestones covering us till then
Zolpi - only regional hence not a huge upfront
CBD - potentially 2 or 3 of these but why would someone pay suda a big upfront when suda don’t own the product? Just developing it.

And with working on bigger upfronts as they said.
005 - we are getting it ready for human trials hence we will have it developed further to sell for more
Anagrelide - working on getting a stable formulation (maybe we can partner with it?? Left field)
003- university working in it to further it along